The council was established in June 2021 to regulate and guide the incorporation of genomics into the UAE’s healthcare systems.

The council works with regulatory, research, technology and medical institutions across the country and oversees all UAE genomic projects. Since its formation, the council has made significant progress in laying a foundation for stakeholders to connect, collaborate and develop qualitative medical applications and services.

The council is chaired by His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi, Chairman of the Abu Dhabi Executive Council.